This segment focuses on the research, development, and commercialization of Deep Transcranial Magnetic Stimulation (Deep TMS) technology for treating mental health disorders. Research and development activities include ongoing clinical trials to expand the therapeutic applications of Deep TMS, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and bipolar disorder. The core technology utilizes H-coils to generate an electromagnetic field that stimulates deeper brain regions compared to traditional TMS. This segment addresses the significant unmet needs in mental health by providing a non-invasive, effective treatment option for patients who have not responded to other therapies. Market positioning emphasizes the company's innovative approach and its FDA-cleared status for various indications. Future opportunities include expanding into new therapeutic areas and geographic markets, as well as developing next-generation Deep TMS systems. Partnerships with clinics and healthcare providers are crucial for market access and patient care.

This segment is dedicated to the application of Deep TMS technology for treating neurological disorders. Research and development efforts are focused on clinical trials and studies to evaluate the efficacy of Deep TMS in conditions such as Alzheimer's disease, Parkinson's disease, and chronic neuropathic pain. The technology utilizes advanced H-coil designs to target specific brain regions associated with these disorders. The patient impact is significant, as Deep TMS offers a non-invasive treatment option for patients with limited treatment choices. Market positioning emphasizes the company's commitment to innovation and its potential to improve the quality of life for patients suffering from neurological conditions. Future opportunities include expanding the range of approved indications and developing new treatment protocols. Regulatory and clinical aspects are critical, with a focus on obtaining FDA clearances and conducting rigorous clinical trials to demonstrate safety and efficacy. Collaborations with hospitals and research institutions are essential for advancing the understanding and application of Deep TMS in neurology.